At Cibus Therapeutics, we believe that collaboration is essential to accelerating scientific discovery and delivering impactful therapies. We actively partner with leading researchers, clinicians, contract research organizations (CROs), and patient advocacy groups to strengthen every stage of our development process—from early discovery to clinical execution. These strategic alliances allow us to integrate diverse expertise, expand access to critical resources, and stay closely connected to patient needs. By working together, we’re not only advancing innovation but also ensuring our therapies are meaningful, effective, and accessible to those who need them most.
Collaborating to advance research and awareness for chronic pancreatitis.
Partner in developing CBT-101 molecule
Supporting preclinical and clinical studies.
Driving operational excellence in clinical trial execution.
Cibus Therapeutics is a clinical-stage biotech company developing innovative small-molecule therapies for chronic pancreatitis and IBD. Based in Palo Alto, we combine science and compassion to improve lives.
Cibus Therapeutics © 2025 | All rights reserved.